BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $35,920,000 | +42.9% | 237,616 | +37.7% | 2.40% | +7.5% |
Q2 2022 | $25,139,000 | +6345.9% | 172,525 | +2775.4% | 2.24% | +2440.9% |
Q3 2020 | $390,000 | -11.2% | 6,000 | 0.0% | 0.09% | -11.1% |
Q2 2020 | $439,000 | +61.4% | 6,000 | -25.0% | 0.10% | +94.1% |
Q1 2020 | $272,000 | -79.2% | 8,000 | -66.7% | 0.05% | -48.5% |
Q4 2019 | $1,307,000 | +13.9% | 24,000 | -12.7% | 0.10% | +37.5% |
Q3 2019 | $1,147,000 | – | 27,500 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |